Characteristics of induced sputum neutrophils and macrophages in patients with chronic obstructive pulmonary disease on a basic therapy
https://doi.org/10.20538/1682-0363-2011-6-52-56
Abstract
Aim of the research — to define the tiotropium bromide influence on bronchial neutrophiles and macrophages morphofunctional properties at stable of chronic obstructive pulmonary disease (COPD). The tiotropium using for 3 months has allowed to improve essentially qualitative characteristics of key effectors cells. The revealed changes were observed in all groups of patients irrespective of a previous mode of COPD treatment.
About the Authors
S. V. Fedosenko
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
G. E. Chernogoryuk
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
N. A. Kirillova
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
A. Yu. Fisenko
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
Ye. P. Roslyakova
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
References
1. Чучалин А.Г. Система оксиданты — антиоксиданты и пути медикаментозной коррекции // Пульмонология. 2004. № 4. С. 111—115.
2. Шмелев Е.И. Воспаление — ключевой элемент прогрессирования хронической обструктивной болезни легких // Consilium medicum. 2003. № 7 (4). С. 5—7.
3. Barczyk A. Decreased levels of MPO in induced sputum of of patients with chronic obstructive pulmonary disease after treatment with oral glucocorticoids // Chest. 2005. 127. Р. 407—415.
4. Barnes P.J. Chronic Obstructive Pulmonary Disease: molecular and cellular mechanisms // Eur. Respir. J. 2003. 22. Р. 672—688.
5. Decramer M., Celli B., Kesten S. et al. on behalf of the UPLIFT (Understending Potetial Long-term impacts on Function with Tiotropium) study investigators. Effect of tiotripium on outcomes in patients with moderate COPD (UPLIFT): a prespecified subgroup analysis of a randomized controlled trial // Lancet. 2009.
6. Frankenberger M., Betz R., Weber N. et al. Characterization of a population of small macrophages in induced sputum of patients with chronic obstructive pulmonary disease and healthy volunteers // Clinical & Experimental Immunology. 2004. 138 (3). Р. 507—516.
7. Hodge S., Hodge G., Scicchitano R. et al. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells // Immunol. Cell. Biol. 2003. 8. Р. 289—296.
8. Hogg J.C., Walker B.A. Polymorphonuclear leucocyte traffic in lung inflammation // Thorax. 1995. 50. Р. 819—820.
9. Kasahara Y., Tuder R.M., Cool C.D. et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema // Am. J. Respir. Crit. Care. Med. 2001. 163. Р. 737—744.
10. Liu C.Y. Apoptotic neutrophils undergoing secondary necrosis induce human lung epithelial cell detachment // J. Biomed. Sci. 2003. 10. Р. 746—756.
11. Niewoehner D.E., K. Rice, C. Cote et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial // Ann. Intern. Med. 2005. V. 143 (5). P. 317—326.
12. Odaka C., Mizuochi T., Yang J. et al. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response // J. Immunol. 2003. 171. Р. 1507— 1514.
13. Owen C.A., Campbell M.A., Sannes P.L. et al. Cell-surfacebound elastase and cathepsin G in human neutrophils: a novel non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases // J. Cell. Biol. 1995. 131. Р. 775—789.
14. Peleman R.A., Rytila P.H., Kips J.C. et al. The cellular composition of induced sputum in chronic obstructive pulmonary disease // Eur. Respir. J. 1999. 13. Р. 839—843.
15. Tashkin D.P., Celli B., Senn S. et al. on behalf of the UPLIFT (Understending Potetial Long-term impacts on Function with Tiotropium) study investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease // N. Engl. J. Med. 2008. V. 359. P. 1543—1554.
16. Teder P., Vandivier R.W., Jiang D. et al. Resolution of lung inflammation by CD44 // Science. 2002. 296. Р. 155—158.
17. Vandivier R.W., Henson P.M., Douglas I.S. Burying the dead. The impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease // Chest. 2006. 129. Р. 1673—1682.
Review
For citations:
Fedosenko S.V., Chernogoryuk G.E., Kirillova N.A., Fisenko A.Yu., Roslyakova Ye.P. Characteristics of induced sputum neutrophils and macrophages in patients with chronic obstructive pulmonary disease on a basic therapy. Bulletin of Siberian Medicine. 2011;10(6):52-56. (In Russ.) https://doi.org/10.20538/1682-0363-2011-6-52-56
Views:
623
Email this article 